Literature DB >> 14659690

Subclinical prion infection.

Andrew F Hill1, John Collinge.   

Abstract

Prion diseases are transmissible neurodegenerative disorders that include scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle and Creutzfeldt-Jakob disease (CJD) in humans. The principal component of the infectious agent responsible for these diseases appears to be an abnormal isoform of the host-encoded prion protein (PrP), designated PrP(Sc). Prion diseases are transmissible to the same or different mammalian species by inoculation with, or dietary exposure to, infected tissues. Although scrapie in sheep has been recognized for over 200 years, it is the recent epidemic of BSE that has centred much public and scientific attention on these neurodegenerative diseases. The occurrence of variant CJD in humans and the experimental confirmation that it is caused by the same prion strain as BSE has highlighted the need for intensive study into the pathogenesis of these diseases and new diagnostic and therapeutic approaches. The existence and implications of subclinical forms of prion disease are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14659690     DOI: 10.1016/j.tim.2003.10.007

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  35 in total

1.  Generation of antisera to purified prions in lipid rafts.

Authors:  Robert Hnasko; Ana V Serban; George Carlson; Stanley B Prusiner; Larry H Stanker
Journal:  Prion       Date:  2010-04-09       Impact factor: 3.931

2.  Enhanced stability of human prion proteins with two disulfide bridges.

Authors:  Tuomas P J Knowles; Ralph Zahn
Journal:  Biophys J       Date:  2006-06-02       Impact factor: 4.033

Review 3.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

4.  Prions, proteinase K and infectivity.

Authors:  Gustavo Sajnani; Jesús R Requena
Journal:  Prion       Date:  2012-10-08       Impact factor: 3.931

5.  Factors determining the potential for onward transmission of variant Creutzfeldt-Jakob disease via surgical instruments.

Authors:  Tini Garske; Hester J T Ward; Paul Clarke; Robert G Will; Azra C Ghani
Journal:  J R Soc Interface       Date:  2006-12-22       Impact factor: 4.118

6.  Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice.

Authors:  Juan Carlos Espinosa; Olivier Andréoletti; Joaquín Castilla; María Eugenia Herva; Mónica Morales; Elia Alamillo; Fayna Díaz San-Segundo; Caroline Lacroux; Séverine Lugan; Francisco Javier Salguero; Jan Langeveld; Juan María Torres
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

8.  In vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoforms.

Authors:  Pedro Fernandez-Funez; Sergio Casas-Tinto; Yan Zhang; Melisa Gómez-Velazquez; Marco A Morales-Garza; Ana C Cepeda-Nieto; Joaquín Castilla; Claudio Soto; Diego E Rincon-Limas
Journal:  PLoS Genet       Date:  2009-06-05       Impact factor: 5.917

9.  Recombinant prion protein induces a new transmissible prion disease in wild-type animals.

Authors:  Natallia Makarava; Gabor G Kovacs; Olga Bocharova; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  Acta Neuropathol       Date:  2010-01-06       Impact factor: 17.088

10.  Detection of sub-clinical CWD infection in conventional test-negative deer long after oral exposure to urine and feces from CWD+ deer.

Authors:  Nicholas J Haley; Candace K Mathiason; Mark D Zabel; Glenn C Telling; Edward A Hoover
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.